ABCD4
protein-codingATP binding cassette subfamily D member 4, the group of ATP binding cassette subfamily D
Gene summary
The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ALD subfamily, which is involved in peroxisomal import of fatty acids and/or fatty acyl-CoAs in the organelle. All known peroxisomal ABC transporters are half transporters which require a partner half transporter molecule to form a functional homodimeric or heterodimeric transporter. The function of this peroxisomal membrane protein is unknown. However, it is speculated that it may function as a heterodimer for another peroxisomal ABC transporter and, therefore, may modify the adrenoleukodystrophy phenotype. It may also play a role in the process of peroxisome biogenesis. Alternative splicing results in several protein-coding and non-protein-coding variants. [provided by RefSeq, Jul 2017]
- PXMP1L
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~17.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0013925
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0013925
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0013925
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0013925
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0013925
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0013925
Submitter: ClinGen
*ABCD4* was first reported in relation to autosomal recessive methylmalonic acidemia with homocystinuria, type cblJ in 2012 (Coelho et al., PMID: 22922874). The primary features of this condition include elevated methylmalonic acid and total homocysteine in blood and/or urine. However, the presentation can be variable and may include hypotonia, anemia, and pigmentation abnormalities of the skin and hair. The underlying mechanism is a failure to transport cobalamin across the lysosomal membrane during uptake, leading to reduced intracellular levels of the enzyme cofactors AdoCbl and MeCbl (PMID: 20301503). Ten variants (missense, in-frame indel, frameshift) that have been reported in nine probands in eight publications (PMIDs: 41378236; 22922874; 23141461; 25234635; 28572511; 30293248; 30651581; 33729671) are included in this curation. Co-segregation with disease has not been observed. Of note, the recurrent variant c.423C>G p.(Asn141Lys) has been reported in a homozygous state in three East Asian probands, and is associated with hyperpigmentation of the skin. The mechanism of pathogenicity is biallelic loss of function. This gene-disease association is also supported by in vitro functional assays, interactions with other proteins involved in cobalamin transport, a zebrafish model, and transgenic rescue in patient cells (PMIDs: 38069516; 22922874; 27456980; 31113616; 33845046). In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was originally approved by the ClinGen General Inborn Errors of Metabolism Gene Curation Expert Panel on September 8, 2023. This gene-disease relationship was re-evaluated on January 23, 2026. As a result of this re-evaluation, the classification did not change.
Clinical Genomic Database (CGD)
Manifestation: Allergy/Immunology/Infectious; Biochemical; Cardiovascular; Neurologic
Intervention: Allergy/Immunology/Infectious; Biochemical; Cardiovascular
Rationale: Administration of hydroxocobalamin/methylcobalamin has been described as beneficial; Due to infectious risks, administration of G-CSF has been described, and early and aggressive treatment of infections may be benefiical; Surveillance for cardiovascular manifestations may allow early management
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ABCD4 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_005050.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 5 | 98 | 4 | 107 | ||
| missense | 2 | 4 | 166 | 21 | 2 | 195 |
| nonsense | 5 | 3 | 1 | 9 | ||
| start loss | 1 | 1 | ||||
| frameshift | 13 | 11 | 2 | 26 | ||
| splice donor/acceptor (+/-2bp) | 1 | 12 | 4 | 17 | ||
| Total | 21 | 30 | 179 | 119 | 6 | 355 |
Highest pathogenic variant AF is 0.000026023337
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_005041.1 | 19 | MANE Select | |
| Ensembl | ENSP00000349396.4 | 19 | MANE Select | |
| RefSeq | NP_001340520.1 | 18 | Standard | |
| RefSeq | NP_001340521.1 | 17 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Peroxisome - Homo sapiens (human)
- ABC transporters - Homo sapiens (human)
- Cobalamin (Cbl, vitamin B12) transport and metabolism
- Metabolism
- Metabolism of water-soluble vitamins and cofactors
Biological Process
- cobalamin metabolic process
- transmembrane transport
- cellular response to leukemia inhibitory factor
Molecular Function
- ATP binding
- ATPase activity, coupled to transmembrane movement of substances
Cellular Component
- lysosomal membrane
- peroxisome
- peroxisomal membrane
- endoplasmic reticulum membrane
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000356924
- Coding exons
- 19
- Length
- 17634
- Individuals with no LoFs
- 125672
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 76
- Defined
- 125748
- p
- 0.000302
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.169 | 347 | 356 | 0.975 | 0.0000211 | 3926 |
| Missense (PolyPhen) | 99 | 111.19 | 0.89039 | 1225 | ||
| Synonymous | -0.725 | 162 | 151 | 1.08 | 0.00000942 | 1200 |
| Loss of Function | 2.06 | 25 | 38.9 | 0.643 | 0.00000203 | 408 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00037 | 0.00037 | rare |
| Latino/Admixed American | 0.000087 | 0.000087 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00054 | 0.00054 | rare |
| Finnish | 0.00019 | 0.00018 | rare |
| European (Non-Finnish) | 0.00038 | 0.00038 | rare |
| South Asian | 0.00016 | 0.00016 | rare |
| Other | 0.00082 | 0.00081 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: May be involved in intracellular processing of vitamin B12 (cobalamin). Could play a role in the lysosomal release of vitamin B12 into the cytoplasm. {ECO:0000269|PubMed:22922874}.;
Recessive Scores
- pRec
- 0.153
Intolerance Scores
- LoFtool
- 0.152
- RVIS EVS
- 0.8
- RVIS percentile EVS
- 87.72
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.413
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | High | High |
| Primary Immunodeficiency | High | High | High |
| Cancer | High | High | High |